Extra Binding Region Induced by Non-Zinc Chelating Inhibitors into the S1′ Subsite of Matrix Metalloproteinase 8 (MMP-8)

被引:77
作者
Pochetti, Giorgio [1 ]
Montanari, Roberta [1 ]
Gege, Christian [2 ]
Chevrier, Carine [2 ]
Taveras, Arthur G. [3 ]
Mazza, Fernando [1 ,4 ]
机构
[1] CNR, Ist Cristallog, Area Ric Roma 1, I-00016 Rome, Italy
[2] Alantos Pharmaceut AG, D-69120 Heidelberg, Germany
[3] Alantos Pharmaceut Inc, Riverside Technol Ctr, Cambridge, MA 02139 USA
[4] Univ Aquila, Dipartimento Sci Salute, I-67010 Laquila, Italy
关键词
HUMAN NEUTROPHIL COLLAGENASE; PYRROLIDINE DERIVATIVES; RHEUMATOID-ARTHRITIS; SELECTIVE-INHIBITION; CRYSTAL-STRUCTURES; TISSUE INHIBITOR; CANCER-THERAPY; GELATINASE-B; DRUG DESIGN; PROTEIN;
D O I
10.1021/jm801166j
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The mode of binding and the activity of the first two non-zinc chelating, potent, and selective inhibitors of human neutrophil collagenase are reported. The crystal structures of the catalytic domain of MMP-8, respectively complexed with each inhibitor, reveals that both ligands are deeply inserted into the primary specificity subsite S-1', where they induce a similar conformational change of the surrounding loop that is endowed with the main specificity determinants of MMPs. Accord to this rearrangement, both inhibitors remove the floor of the pocket formed by the Y227 side-chain, rendering available an extra binding region never explored before. The present data show that potent and more selective inhibitors can be obtained by developing ligands able to interact with the selectivity regions of the enzyme rather than with the catalytic zinc ion, which is the common feature of all MMP members.
引用
收藏
页码:1040 / 1049
页数:10
相关论文
共 56 条
[31]  
Matter H, 2004, CURR OPIN DRUG DISC, V7, P513
[32]   Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12 [J].
Morales, R ;
Perrier, S ;
Florent, JM ;
Beltra, J ;
Dufour, S ;
De Mendez, I ;
Manceau, P ;
Tertre, A ;
Moreau, F ;
Compere, D ;
Dublanchet, AC ;
O'Gara, M .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 341 (04) :1063-1076
[33]   Hydroxamic acids as pharmacological agents [J].
Muri, EMF ;
Nieto, MJ ;
Sindelar, RD ;
Williamson, JS .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (17) :1631-1653
[34]   AMORE - AN AUTOMATED PACKAGE FOR MOLECULAR REPLACEMENT [J].
NAVAZA, J .
ACTA CRYSTALLOGRAPHICA SECTION A, 1994, 50 :157-163
[35]  
Nuti E, 2007, CURR PHARM DESIGN, V13, P2087
[36]   H-31 HUMAN BREAST-CANCER CELLS STIMULATE TYPE-I COLLAGENASE PRODUCTION IN OSTEOBLAST-LIKE CELLS AND INDUCE BONE-RESORPTION [J].
OHISHI, K ;
FUJITA, N ;
MORINAGA, Y ;
TSURUO, T .
CLINICAL & EXPERIMENTAL METASTASIS, 1995, 13 (04) :287-295
[37]   Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy [J].
Overall, CM ;
Kleifeld, O .
NATURE REVIEWS CANCER, 2006, 6 (03) :227-239
[38]   Strategies for MMP inhibition in cancer:: Innovations for the post-trial era [J].
Overall, CM ;
López-Otín, C .
NATURE REVIEWS CANCER, 2002, 2 (09) :657-672
[39]   LOCALIZATION OF TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES IN ALZHEIMERS-DISEASE AND NORMAL BRAIN [J].
PERESS, N ;
PERILLO, E ;
ZUCKER, S .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (01) :16-22
[40]   Insight into the structural determinants for selective inhibition of matrix metalloproteinases [J].
Pirard, Bernard .
DRUG DISCOVERY TODAY, 2007, 12 (15-16) :640-646